Sec Form 4 Filing - DENT MICHAEL T @ HealthLynked Corp - 2024-03-27

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
DENT MICHAEL T
2. Issuer Name and Ticker or Trading Symbol
HealthLynked Corp [ HLYK]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director X __ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
Chief Executive Officer
(Last) (First) (Middle)
1265 CREEKSIDE PKWY,, SUITE 302
3. Date of Earliest Transaction (MM/DD/YY)
03/27/2024
(Street)
NAPLES, FL34108
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
12% Convertible Notes $ 0.0573 03/27/2024 J( 1 ) 03/27/2024 06/27/2025 Common stock 6,108,202 ( 2 ) $ 350,000 $ 350,000 I Held by Trust ( 3 )
12% Convertible Notes $ 0.0573 03/27/2024 J( 1 ) 03/27/2024 09/20/2025 Common stock 2,905,759 ( 2 ) $ 166,500 $ 166,500 I Held by Trust ( 3 )
12% Convertible Notes $ 0.05 04/18/2024 J( 1 ) 04/18/2024 04/18/2025 Common stock 1,000,000 ( 2 ) $ 50,000 $ 50,000 I Held by Trust ( 3 )
12% Convertible Notes $ 0.033 12/04/2024 J( 1 ) 12/04/2024 05/04/2025 Common stock 757,576 ( 2 ) $ 25,000 $ 25,000 I Held by Trust ( 3 )
12% Convertible Notes $ 0.026 12/17/2024 J( 1 ) 12/17/2024 06/17/2025 Common stock 2,692,308 ( 2 ) $ 70,000 $ 70,000 I Held by Trust ( 3 )
12% Convertible Notes $ 0.023 12/31/2024 J( 1 ) 12/31/2024 07/01/2025 Common stock 5,217,391 ( 2 ) $ 120,000 $ 120,000 I Held by Trust ( 3 )
Warrants $ 0.0226 12/31/2024 J( 4 ) 618,750 12/31/2024 12/31/2034 Common stock 618,750 $ 0 ( 4 ) 618,750 I Held by Trust ( 3 )
Warrants $ 0.05 01/01/2025 J( 5 ) 2,000,000 01/01/2015 01/01/2025 Common stock 2,000,000 ( 6 ) 0 D
Warrants $ 0.065 01/01/2025 J( 5 ) 6,678,462 02/12/2018 01/01/2025 Common stock 6,678,462 ( 7 ) 0 D
12% Convertible Notes $ 0.049 03/04/2025 J( 1 ) 03/04/2025 09/04/2025 Common stock 1,020,408 ( 2 ) $ 50,000 $ 50,000 I Held by Trust ( 3 )
12% Convertible Notes $ 0.03 03/12/2025 J( 1 ) 03/12/2025 09/12/2025 Common stock 2,000,000 ( 2 ) $ 60,000 $ 60,000 I Held by Trust ( 3 )
12% Convertible Notes $ 0.0375 03/20/2025 J( 1 ) 03/20/2025 09/20/2025 Common stock 11,200,000 ( 2 ) $ 420,000 $ 420,000 I Held by Trust ( 3 )
Warrants $ 0.0375 03/20/2025 J( 4 ) 1,353,356 03/20/2025 03/20/2035 Common stock 1,353,356 $ 0 ( 4 ) 1,353,356 I Held by Trust ( 3 )
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
DENT MICHAEL T
1265 CREEKSIDE PKWY,
SUITE 302
NAPLES, FL34108
X X Chief Executive Officer
Signatures
/s/ Michael Dent 03/24/2025
Signature of Reporting Person Date
Explanation of Responses:
( 1 )The reporting person's trust purchased this convertible note from the Issuer.
( 2 )Excludes shares issuable at the election of the reporting person upon conversion of accrued interest into shares of common stock.
( 3 )Held beneficially by the Mary S. Dent Gifting Trust dated January 31, 2006. The reporting person is the trustee of such trust.
( 4 )The reporting person's trust received warrants to purchase shares of Issuer's common stock as partial consideration for a 6-month extension of previously issued convertible promissory notes.
( 5 )Warrants expired unexercised.
( 6 )The reporting person received the above warrants in 2015 as consideration for accrued interest on then-outstanding loans. The warrants expired unexercised on January 1, 2025.
( 7 )The reporting person received the above warrants in 2018 as an inducement to extend the maturity dates on then-outstanding loans. The warrants expired unexercised on January 1, 2025.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.